Clinical Trials Directory

Trials / Completed

CompletedNCT04266964

Validity and Reliability Study of the Muscle Excitability Scale in Spinal Cord Injury Patients

Muscle Excitability Scale for Assessment of Spastic Reflexes in Spinal Cord Injury. Part II: Validity and Reliability Study

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
University Hospital, Motol · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to verify validity and reliability of the Muscle excitability scale (MES), which has been developed to access muscle susceptibility to spasms and/or clones as part of spastic motor behavior in spinal cord injured patients.

Detailed description

The muscle excitability scale (MES) is intended for patients after spinal cord injury. The objective is to evaluate a motor response (muscle spasms or clones) to a sensory or motor stimulus. A sensory stimulus is created by thumb and pointfinger compression of cutaneous tissue on the inside part of the middle thigh and calf. A motor stimulus is created by passive movement of the lower limb to flexion and extension. The MES grades from 0 to 4 reflect the muscle spastic or clonic tendency and the extent of this motor response (from isolated to generalized). Two investigators will examine a spastic motor behavior in 50 chronic SCI subjects using MES, Modificated Ashworth Scale (MAS) and Penn Spasms Frequency Scale (PSFS) to verify the validity and reliability of the MES.

Conditions

Interventions

TypeNameDescription
PROCEDUREManual examinationWith the patient in a supine position, squeeze the skinfold between your thumb and pointfinger on the inner aspect of the middle third of the thigh and on the inner aspect of the middle third of the calf. Place your hand under the proximal calf and the heel and move the leg into maximum flexion at the hip and knee joints. After the response, if any, is completed, move the limb back into full extension. Each of these movements lasts for one second.

Timeline

Start date
2020-01-02
Primary completion
2023-01-31
Completion
2023-02-25
First posted
2020-02-12
Last updated
2023-03-14

Locations

2 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT04266964. Inclusion in this directory is not an endorsement.